What the six lenses say about AARTIDRUGS — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How AARTIDRUGS’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | -1.5pp | +4.0pp | +6.4pp | +12.7pp | +21.2pp | -7.3pp |
Nifty 500 Broad-market baseline | -1.6pp | +4.0pp | +5.4pp | +11.1pp | +15.5pp | -12.6pp |
Sector Own-sector index | — | — | +2.5pp | +5.1pp | +2.3pp | -33.4pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
AARTIDRUGS daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
AARTIDRUGS ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 555 | 598 | 557 | 677 | 591 | 653 | 602 | 720 |
| ↳ change QoQ | — | +7.7% | -7.0% | +21.6% | -12.7% | +10.5% | -7.8% | +19.6% |
| EBITDA (₹cr) | 66 | 69 | 74 | 93 | 74 | 84 | 55 | 96 |
| EBITDA margin | 11.9% | 11.5% | 13.2% | 13.7% | 12.5% | 12.9% | 9.1% | 13.3% |
| PAT (₹cr) | 33 | 35 | 37 | 63 | 54 | 45 | 41 | 55 |
| ↳ change QoQ | — | +5.1% | +6.1% | +69.9% | -14.3% | -16.7% | -8.9% | +34.1% |
| Net margin | 6.0% | 5.8% | 6.7% | 9.3% | 9.1% | 6.9% | 6.8% | 7.6% |
| EPS (₹) | 3.62 | 3.83 | 4.06 | 6.89 | 5.91 | 4.96 | 4.44 | 6.05 |
| D/E | 0.00 | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding AARTIDRUGS (3)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| DSP Small Cap Reg Gr | 1.34% | 20,221 | |
| ICICI Pru Pharma Healthcare Diag Gr | 1.16% | 6,803 | |
| DSP Healthcare Fund Reg Gr | 0.99% | 3,639 |
ETFs holding AARTIDRUGS (0)
No tracked ETF holds AARTIDRUGS ≥0.5%.